CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 43 enrolled
Drug / intervention
Chloroprocaine +3 moredrug
Likely dose
Chloroprocaine 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02862912
NCT02862912Phase 4Completed
CompareCT.gov

Chloroprocaine Versus Bupivacaine Spinal Anesthesia for Cervical Cerclage

Columbia University·interventional·Posted Aug 11, 2016·Updated Dec 24, 2020

In Brief

A Phase 4 clinical trial evaluating Chloroprocaine, Bupivacaine, and 2 other interventions for Adverse Reaction to Spinal Anesthetic and Maternal Care for Cervical Incompetence. Completed, enrolled 43 participants across 1 site.

Detailed Summary

This study aims to determine whether or not spinal anesthesia with the local anesthetic drug, chloroprocaine, wears off faster than the local anesthetic drug, bupivacaine, and results in faster discharge from the post-anesthesia care unit after surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdverse Reaction to Spinal Anesthetic, Maternal Care for Cervical Incompetence
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedAug 11, 2016
Enrollment StartNov 8, 2016
Primary CompletionJan 31, 2020
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 9.9 years ago

Interventions

Chloroprocainedrug

Administered as a single injection or continuously through an indwelling catheter - 50 mg

Bupivacainedrug

A dextrose Solution is usually given as an injection - 9 mg (1.4 ml)

Fentanyldrug

15 mcg Fentanyl will be included int he spinal anesthetic in both groups

Salinedrug

Preservative free normal saline (0.3 ml) to bring the volume to \~ 2 ml